Blood Coagulation & Fibrinolysis

Article	Citations
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery	50
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer	17
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations	16
Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type	13
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency	13
Concurrent congenital hemophilia B and acquired hemophilia A: a unique case report	13
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review	10
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency	10
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe	9
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII	9
Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre	9
Characterization of antibody clones that bind exclusively to insoluble fibrin	9
Harmonizing factor assay-related testing performed in a large laboratory network	9
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	8
Prenatal diagnosis for hemophilia A (intron 22 inversion) reveals a rare association with Klinefelter syndrome with diagnostic difficulties in molecular interpretation	7
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study	7
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians	7
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada	7
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	7
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose	6
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score	6
Efficacy and relative safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: a systematic review and meta-analysis	6
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates	6
Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia	6
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays	6

Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans	6
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT	5
Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation	5
Evaluation of the impact of changes in the autopsy rate on mortality trend of pulmonary embolism, Finland, 1996–2017	5
Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis	5
A rare case of essential thrombocythemia with pseudo-hyperkalemia	5
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests	5
The link between high factor VIII to protein C ratio values and poor liver function after major hepatectomy	5
Fibrinogen Aα gene genotyping in patients with inherited afibrinogenemia deficiency; a novel mutation in Iranian afibrinogenemia patients	5
A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients	4
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience	4
Endothelium-biomarkers for postthrombotic syndrome: a case–control study	4
Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study	4
Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation	4
Naive haemophilia mice displayed different pattern of cytokine profiles of cytokine profiles changes might be associated with subclinical bleeding	4
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing	4
New treatments for primary immune thrombocytopenia	4
Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report	4
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms	4
Identification of two novel mutations in three children with congenital factor VII deficiency	4
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?	4
Two heterozygous mutations associated with type I protein C deficiency in two Chinese independent families	4
Optimizing factor VIII dosing in obese individuals with haemophilia A	4
Expression and methylation status of vascular endothelial growth factor and thrombospondin-1 genes in congenital factor XIII-deficient patients with intracranial hemorrhage	3
Protein S contributes to the paradoxical increase in thrombin generation by low-dose dabigatran in the presence of thrombomodulin	3
Diagnosis of Immunoglobulin G4-related disease in a child with ligneous conjunctivitis: a novel mutation in plasminogen gene and plasminogen activator inhibitor-1 polymorphism	3
Identification of a recurrent missense mutation in the FGA gene likely causing a congenital fibrinogen disorder	3
New developments in the diagnosis of primary immune thrombocytopenia	3
The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection	3
A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay	3
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?	3
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens	3
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding	3
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency	3
Efficacy of extended microthrombolysis in an elderly lady with purpura fulminans	3
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study	3
Rotational thromboelastometry for diagnosis of fibrinolysis induced by urokinase in an in-vitro model	3
Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort	3
Improved prevention of bleeding episodes with emicizumab in 3 patients with concomitant hemophilia A and von Willebrand disease	3
Multiple thrombotic sources and embolic events at arterial sites in a patient with protein-C deficiency	3
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease	3
A refugee child with multiple patterned ecchymoses: a diagnostic dilemma between nonaccidental injury and primary hemostatic defect	3
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection	3
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia	3
Resolution of cardiac surgical bleeding with the combination of 4-factor prothrombin complex concentrate and fresh frozen plasma following lack of response to fresh frozen plasma alone in a patient wi	3
Characteristics of factor V and protein C based on results from Korean testing centers	2
True vs. false immune-mediated thrombotic thrombocytopenic purpura exacerbations: a clinical case in the caplacizumab era	2
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays	2
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome	2
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen	2

Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency	2
Joint deficiency of coagulation factors VII and IX: a case report	2
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene	2
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	2
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient	2
Addressing the haemophilia healthcare crisis amidst Taliban rule: a call to action	2
Hemophilia in the south of Tunisia	2
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding	2
Reversal of life-threatening bleeding with protamine sulfate in a patient with plasma cell leukemia	2
Clot waveform analysis in acute promyelocytic leukemia	2
Uvaol alleviates oxidative stress induced human umbilical vein endothelial cell injury by suppressing mitogen-activated protein kinase signaling pathway	2
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier	2
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays	2
Screening hemostatic defects in Saudi University students with unexplained menorrhagia: a diagnosis, which could be missed	2
Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience	2
Self-limited thrombotic thrombocytopenic purpura	2
The effect of tranexamic acid on myocardial injury in cardiac surgical patients: a systematic review and meta-analysis	2
Comment on: coagulopathy following Crotaline snakebites in northeast Florida	2
Utility of the international society on thrombosis and hemostasis-bleeding assessment tool in the diagnosis of patients who suspected of platelet function disorders	2
Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report	2
Inferior Vena Cava agenesis presenting as deep vein thrombosis in an eight year-old girl	2
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment	2
Diagnosis and treatment of coagulopathy using thromboelastography with platelet mapping is associated with decreased risk of pulmonary failure in COVID-19 patients	2
Clot waveform analysis in hemophilia carriers	2
Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey	2
Obesity and physical exercise in hemophilia	2
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities	2
Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia	2
Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study	2
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system	2
Evaluation of paediatric immune thrombocytopenia patients with clinical and laboratory findings: emphasizing the role of monocytosis	1
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding	1
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab	1
Clinical characteristics and outcomes of patients with isolated pulmonary embolism	1
Soluble thrombomodulin and cardiovascular disease risk factors in Japanese children	1
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura	1
Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban	1
Homozygous methylentetrahydrofolate reductase C667T genotype anticipates age at venous thromboembolism by one decade	1
Clinical phenotype and F7 gene genotype in 40 Tunisian patients with congenital factor VII deficiency	1
The procoagulant potential before and after surgery for endometriosis and its association with disease severity	1
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations	1
A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications	1
Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma	1
Bleeding disorders in Saudi Arabia, causes and prevalence: a review	1
Once-weekly prophylaxis regimen of nonacog alfa in patients with hemophilia B: an analysis of timing of bleeding event onset	1
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases	1
Recommendations for the treatment of immune thrombocytopenia in adults: a comparison	1
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology	1
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate	1
Molecular heterogeneity of factor XI deficiency in Tunisia	1
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	1
Involvement of monocyte-derived extracellular vesicle-associated tissue factor activity in convallatoxin-induced hypercoagulability	1
Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus	1
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies	1
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage	1
Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis	1
Effect of hemolysis on D-dimer testing measured with the Improgen kit: is all manufacturer information correct?	1
COVID-19 vaccination prevents venous thrombosis in patients with SARS-CoV-2 infection and thereafter	1
The role of immune status, viral co-infections and paraproteinemia in development of venous thromboembolism in HIV	1
Refractory acquired haemophilia A in a patient with HIV treated with Emicizumab	1
Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma	1
Challenges, questions and opportunities with regard to the new relationship between clinical practice and the haemostasis laboratory	1
Frequency, clinical, and laboratory findings of platelet secretion disorders in patients referred to the specialized coagulation laboratory of the Iranian Blood Transfusion Organization	1
Levels of procoagulant microparticles expressing phosphatidylserine contribute to bleeding phenotype in patients with inherited thrombocytopenia	1
Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins	1
The role of genetics in the diagnosis and treatment of haemorrhagic diathesis: a historical perspective	1
Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products	1
Whole blood viscosity in patients with aortic stenosis	1
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	1
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice	1
A homozygous loss-of-function mutation in GP1BB causing variable clinical phenotypes in a family with Bernard–Soulier syndrome	1
Disability and the social impact of hemophilia	1
Physician practices in evaluation and treatment of patients with generalized joint hypermobility and bleeding	1
The role of thrombin in haemostasis	1
Nonpharmacological treatment for coping with pain	1
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience	1
Multiple venous thrombosis caused by F9 gene duplication and treated with catheter-directed thrombolysis, AngioJet-assisted pharmaco-mechanical thromboectomy and manual aspiration thromboectomy	1
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period	1
Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States	1
In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant	1

Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma	1
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation	1
Immune thrombocytopenia: options and new perspectives	1
Interpreting coagulation mixing study results in the era of direct oral anticoagulants	1
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran	1
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency	0
Identification of a novel mutation in congenital afibrinogenemia in Iranian patients	0
Cancer-associated thrombosis: the role of inherited thrombophilia	0
Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China	0
Diagnosing rare bleeding disorders	0
Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia	0
HbA1c/C-peptide ratio is associated with angiographic thrombus burden and short-term mortality in patients presenting with ST-elevation myocardial infarction	0
Clinical factors associated with adverse outcomes in the acute period of management of submassive pulmonary embolism	0
Evaluation of 4Ts score inter-rater agreement in patients undergoing evaluation for heparin-induced thrombocytopenia	0
Coronavirus disease 2019 in patients with chronic immune thrombocytopenia on thrombopoietin receptor agonists: new perspectives and old challenges	0
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study	0
Thrombohaemorhhagic balance in coronavirus disease 2019 and its management: a perspective	0
Fibrinolytic drugs induced hemorrhage: mechanisms and solutions	0
Is dynamic change in mean platelet volume related with composite endpoint development after transcatheter aortic valve replacement?	0
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients	0
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism	0
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019	0
Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits	0
Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey	0
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial	0
Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives	0
To do or not to do mixing study in the era of integrated testing for lupus anticoagulant	0
Challenges in managing severe homozygous protein c deficiency: a case report	0
Maternal thrombin generation and D-dimer levels in obesity and pregnancy: results from the maternal thrombin generation in obesity and pregnancy (MaTOPs) study	0
Exploring antithrombin: insights into its physiological features, clinical implications and analytical techniques	0
Sustained good response to rituximab in acquired von Willebrand syndrome	0
Cost-effectiveness of thrombotic thrombocytopenic purpura diagnosis: a retrospective analysis in the University Hospital Center of Lyon (France)	0
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening	0
Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study	0
Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia	0
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage	0
Monitoring of new therapies for hemophilia	0
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study	0
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery	0
Measuring coagulopathy in pediatric craniofacial surgery	0
Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications	0
Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma	0
Apoptosis in platelets from adult patients with chronic idiopathic thrombocytopenic purpura	0
Variation among venous thromboembolism risk assessment tools for postcesarean patients: a retrospective cohort study	0
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma	0
The utility and complications of plasma administration in cirrhotic patients undergoing minimally invasive procedures	0
Microparticles: a link to increased thrombin generation	0
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants	0
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	0
Readability and quality assessment of internet-based patient education materials related to deep vein thrombosis	0
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency	0
A challenging case of heparin-induced skin necrosis without thrombocytopenia	0
Genetic analysis of compound heterozygous pathogenic variants of the F11 gene in two Chinese patients with hereditary factor XI deficiency	0
Falsely prolonged prothrombin time test in a patient with erythrocytosis: a case report	0
Disseminated intravascular coagulation in acute leukemia patients	0
Human coagulation factor IX: a systematic review of its characteristics	0
Hematological treatment and prophylaxis in patients with and without inhibitors	0
Thrombopoietin receptor agonist and rituximab combination therapy in patients with refractory primary immune thrombocytopenia	0
Why do patients with antiphospholipid syndrome bleed? A clinical paradox	0
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population	0
Antiphospholipid syndrome after streptococcal toxic shock syndrome later diagnosed as Behcet's disease	0
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice	0
Hemostatic cover in orthopedic surgery	0
Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review	0
Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic	0
Excluding JAK2 V617F mutation analysis from the primary immune thrombocytopenia ‘diagnosis of exclusion’	0
Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis	0
Mixing studies for lupus anticoagulant: does it matter how we mix?	0
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	0
Relationship between oxidant-antioxidant status and hypercoagulobility indices in children with iron deficiency anaemia	0
Venous thromboembolism and acute myeloid leukemia: risk factors and mortality in elderly white, black and Asian patients	0
Optimal dosing of bemiparin for deep vein thrombosis treatment in children: a retrospective study	0
Evaluation of the activated partial thromboplastin time and its influential factors in ischemic heart disease patients under heparin treatment	0
Management of autoimmune factor XIII deficiency in a frail, elderly patient	0
Elevated CD9 expression as a potential biomarker for diagnosis of Bernard-Soulier syndrome	0
Importance of circulating monocyte subpopulations and Fcγ receptors in immune thrombocytopenia	0
Application of microfluidic chip technology to study the inhibitory effect of tetramethylpyrazine on platelet aggregation, activation, and phosphatidylserine exposure mediated by pathological high she	0
P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia	0
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients	0
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes	0
Utilization and safety of off-label prothrombin complex concentrate (4F-PCC) in a nonsurgical population	0
Use of thrombolytic agents to treat neonatal thrombosis in clinical practice	0
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus	0
Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience	0
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report	0
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?	0
Orthopedic surgical procedures in people with hemophilia	0
How complicated can be a case with immune thrombocytopenic purpura?: postsplenectomy arterial thrombosis	0
The role of eosinophil counts and megakaryocyte nuclei for distinction of acute and chronic immune thrombocytopenic purpura	0
A multicentre real-world data study to assess the bleeding rate and management of patients with haemophilia A and factor VIII inhibitors in Argentina	0
Compound heterozygosity for novel von Willebrand factor genetic variants associated with von Willebrand disease in two Chinese patients	0
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets	0
Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers	0
Haemophilic arthropathy: basic protocols for clinical examination and imaging	0
A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal	0